Realizing the Potential of Metabolomics in Heart Failure: Signposts on the Path to Clinical Utility.
Publication
, Journal Article
Shah, SH; Hunter, WG
Published in: JACC Heart Fail
November 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
November 2017
Volume
5
Issue
11
Start / End Page
833 / 836
Location
United States
Related Subject Headings
- Metabolomics
- Humans
- Heart Failure
- Energy Metabolism
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, S. H., & Hunter, W. G. (2017). Realizing the Potential of Metabolomics in Heart Failure: Signposts on the Path to Clinical Utility. JACC Heart Fail, 5(11), 833–836. https://doi.org/10.1016/j.jchf.2017.08.025
Shah, Svati H., and Wynn G. Hunter. “Realizing the Potential of Metabolomics in Heart Failure: Signposts on the Path to Clinical Utility.” JACC Heart Fail 5, no. 11 (November 2017): 833–36. https://doi.org/10.1016/j.jchf.2017.08.025.
Shah SH, Hunter WG. Realizing the Potential of Metabolomics in Heart Failure: Signposts on the Path to Clinical Utility. JACC Heart Fail. 2017 Nov;5(11):833–6.
Shah, Svati H., and Wynn G. Hunter. “Realizing the Potential of Metabolomics in Heart Failure: Signposts on the Path to Clinical Utility.” JACC Heart Fail, vol. 5, no. 11, Nov. 2017, pp. 833–36. Pubmed, doi:10.1016/j.jchf.2017.08.025.
Shah SH, Hunter WG. Realizing the Potential of Metabolomics in Heart Failure: Signposts on the Path to Clinical Utility. JACC Heart Fail. 2017 Nov;5(11):833–836.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
November 2017
Volume
5
Issue
11
Start / End Page
833 / 836
Location
United States
Related Subject Headings
- Metabolomics
- Humans
- Heart Failure
- Energy Metabolism
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology